Education
About Us
Working with TipRanks
Follow Us
Strata Critical Medical, Inc. (SRTA)
NASDAQ:SRTA
SRTA Stock Chart & Stats
$4.68
--
Market closed
$4.68
--
Day’s Range― - ―
52-Week Range$2.35 - $6.02
Previous CloseN/A
VolumeN/A
Average Volume (3M)740.61K
Market Cap
$369.65M
Enterprise Value$368.50M
Total Cash (Recent Filing)$75.92M
Total Debt (Recent Filing)$3.47M
Price to Earnings (P/E)―
Beta2.04
Next Earnings
Mar 03, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding86,366,520
10 Day Avg. Volume668,182
30 Day Avg. Volume740,611
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)1.48
Price to Sales (P/S)1.32
P/FCF Ratio-9.27
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue1.61
Enterprise Value/Gross Profit6.83
Enterprise Value/Ebitda-14.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.41
Revenue Forecast (FY)$270.00M
Bulls Say, Bears Say
Bulls Say
Low Leverage & Strong ROEExtremely low leverage paired with a 17.05% TTM ROE indicates strong capital efficiency and limited financial risk. This durable balance sheet gives flexibility to fund operations or acquisitions and absorb shocks without heavy interest burdens or rapid equity dilution.
Strategic Repositioning Via TransactionsDivesting noncore passenger operations and acquiring Keystone refocuses the company on organ recovery and logistics, concentrating management and resources on a coherent, higher-growth segment. This structural shift should improve strategic clarity and long-term operating performance.
Medical Segment Margin & GrowthSustained double-digit revenue growth and a marked jump in adjusted EBITDA margins (>15%) in the medical segment reflect scalable unit economics. Durable margin expansion supports predictable free cash flow generation and reinvestment capacity as organ logistics scale.
Bears Say
Declining Aggregate Revenue TrendA multi-period revenue decline signals weak organic demand or market share erosion. Persistent top-line contraction reduces operating leverage and makes margin recovery and sustainable cash generation harder, increasing dependence on acquisitions or cost measures to meet targets.
Weak Cash Flow ConversionNegative operating and free cash flow despite reported profits indicate poor cash conversion, creating structural funding risk. Volatile FCF growth suggests earnings are not reliably producing cash, raising refinancing, dilution, or constrained investment risk over the medium term.
Legal Provision From Go-Public TransactionAn active legal provision tied to the go-public transaction introduces contingent liability and operational distraction. Potential settlements or ongoing legal costs could consume cash, limit capital allocation to growth initiatives, and increase uncertainty about sustainable free cash flow.
Strata Critical Medical News
SRTA FAQ
What was Strata Critical Medical, Inc.’s price range in the past 12 months?
Strata Critical Medical, Inc. lowest stock price was $2.35 and its highest was $6.02 in the past 12 months.
What is Strata Critical Medical, Inc.’s market cap?
Strata Critical Medical, Inc.’s market cap is $369.65M.
When is Strata Critical Medical, Inc.’s upcoming earnings report date?
Strata Critical Medical, Inc.’s upcoming earnings report date is Mar 03, 2026 which is today.
How were Strata Critical Medical, Inc.’s earnings last quarter?
Currently, no data Available
Is Strata Critical Medical, Inc. overvalued?
According to Wall Street analysts Strata Critical Medical, Inc.’s price is currently Overvalued.
Does Strata Critical Medical, Inc. pay dividends?
Strata Critical Medical, Inc. does not currently pay dividends.
What is Strata Critical Medical, Inc.’s EPS estimate?
Strata Critical Medical, Inc.’s EPS estimate is 0.01.
How many shares outstanding does Strata Critical Medical, Inc. have?
Strata Critical Medical, Inc. has 86,366,520 shares outstanding.
What happened to Strata Critical Medical, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Strata Critical Medical, Inc.?
Currently, no hedge funds are holding shares in SRTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Strata Critical Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
SRTA Sentiment 50%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $97.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.62%
12-Months-Change
Fundamentals
Return on Equity
-10.33%
Trailing 12-Months
Asset Growth
18.43%
Trailing 12-Months
Company Description
Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
SRTA Company Deck
SRTA Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, successful strategic transactions, and strong profit margins, setting a positive outlook for future cash flow generation. However, challenges such as the impact of the Joby transaction stock price and ongoing legal issues were noted.View all SRTA earnings summariesTechnical Analysis
―
AerSale Corporation
―
Sun Country Airlines Holdings
―
flyExclusive
―
Surf Air Mobility, Inc.
―
Ownership Overview
13.74% Insiders
10.16% Mutual Funds
2.31% Other Institutional Investors
56.65% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---